07:24 AM EDT, 08/06/2024 (MT Newswires) -- IDEXX Laboratories ( IDXX ) reported Q2 adjusted earnings Tuesday of $3.02 per diluted share, up from $2.63 a year earlier.

Analysts polled by Capital IQ expected $2.87.

Revenue for the quarter ended June 30 was $1 billion, up from $943.6 million a year earlier.

Analysts polled by Capital IQ expected $1 billion.

The company said it now expects 2024 revenue of $3.89 billion to $3.95 billion, down from $3.9 billion to $3.97 billion previously. Analysts surveyed by Capital IQ are looking for $3.94 billion.